Literature DB >> 23657604

Angiotensin-converting enzyme (ACE) gene polymorphisms are associated with idiopathic pulmonary fibrosis.

Soo-Taek Uh1, Tae-Hoon Kim, Eun-Young Shim, An-Soo Jang, Sung-Woo Park, Jong-Sook Park, Byung-Lae Park, Byoung Whui Choi, Hyoung Doo Shin, Dong Soon Kim, Choon-Sik Park.   

Abstract

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is characterized by progressive dyspnea and worsening lung function. ACE is increased in the bronchoalveolar lavage fluid from patients with IPF, suggesting the role of ACE in the pathogenesis of IPF. We evaluated the role of single-nucleotide polymorphisms (SNPs) in the development risk of IPF.
METHODS: Two-hundred twenty patients with IPF and 456 healthy subjects were included in this study. Eleven polymorphisms were selected among those reported previously. Genotype was performed by single base extension.
RESULTS: Although absolute LD (|D'|= 1 and r(2 )= 1) was not present, 11 SNPs showed tight LDs. The logistic analysis of the all of 11 SNPs on the ACE genes between patients with IPF and healthy subjects were found to be related with the risk of IPF in recessive type. However, in patients with IPF diagnosed by surgical lung biopsy, only two SNP of -5538T>C and +21288_insdel SNPs were related with the risk of IPF in co-dominant type, and there were no SNPs related with the risk of IPF in dominant type. In patients with IPF diagnosed by clinical criteria or surgical lung biopsy, four SNPs on promoter (-5538T>C, -5508A>C, -3927T>C, -115T>C), one on intron (+15276A>G), one on exon (+21181G>A), and one in three prime region (+21288_insdel) were related with the risk of IPF.
CONCLUSIONS: This study showed a newly discovered SNP of ACE associated with the risk of development of IPF. ACE -5538T>C and -5508A>C significantly associated with risk of IPF in Korea.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23657604     DOI: 10.1007/s00408-013-9469-1

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  27 in total

1.  Haplotype variation and linkage disequilibrium in 313 human genes.

Authors:  J C Stephens; J A Schneider; D A Tanguay; J Choi; T Acharya; S E Stanley; R Jiang; C J Messer; A Chew; J H Han; J Duan; J L Carr; M S Lee; B Koshy; A M Kumar; G Zhang; W R Newell; A Windemuth; C Xu; T S Kalbfleisch; S L Shaner; K Arnold; V Schulz; C M Drysdale; K Nandabalan; R S Judson; G Ruano; G F Vovis
Journal:  Science       Date:  2001-07-12       Impact factor: 47.728

2.  Adult familial cryptogenic fibrosing alveolitis in the United Kingdom.

Authors:  R P Marshall; A Puddicombe; W O Cookson; G J Laurent
Journal:  Thorax       Date:  2000-02       Impact factor: 9.139

Review 3.  Lung inflammation and fibrosis.

Authors:  P A Ward; G W Hunninghake
Journal:  Am J Respir Crit Care Med       Date:  1998-04       Impact factor: 21.405

Review 4.  Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification.

Authors:  A L Katzenstein; J L Myers
Journal:  Am J Respir Crit Care Med       Date:  1998-04       Impact factor: 21.405

5.  Incidence and prevalence of idiopathic pulmonary fibrosis.

Authors:  Ganesh Raghu; Derek Weycker; John Edelsberg; Williamson Z Bradford; Gerry Oster
Journal:  Am J Respir Crit Care Med       Date:  2006-06-29       Impact factor: 21.405

Review 6.  Idiopathic pulmonary fibrosis.

Authors:  T J Gross; G W Hunninghake
Journal:  N Engl J Med       Date:  2001-08-16       Impact factor: 91.245

7.  Lymphokines in bleomycin-induced lung injury in bleomycin-sensitive C57BL/6 and -resistant BALB/c mice.

Authors:  I Gur; R Or; M J Segel; M Shriki; G Izbicki; R Breuer
Journal:  Exp Lung Res       Date:  2000 Oct-Nov       Impact factor: 2.459

Review 8.  Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy.

Authors:  M Selman; T E King; A Pardo
Journal:  Ann Intern Med       Date:  2001-01-16       Impact factor: 25.391

9.  Association of tumor necrosis factor polymorphisms with asthma and serum total IgE.

Authors:  Hyoung Doo Shin; Byung Lae Park; Lyoung Hyo Kim; Ji Hyun Jung; Hoe Jin Wang; Young Joo Kim; Hae-Sim Park; Soo-Jong Hong; Byoung Whui Choi; Do-Jin Kim; Choon-Sik Park
Journal:  Hum Mol Genet       Date:  2003-12-17       Impact factor: 6.150

Review 10.  Angiotensin-TGF-beta 1 crosstalk in human idiopathic pulmonary fibrosis: autocrine mechanisms in myofibroblasts and macrophages.

Authors:  Bruce D Uhal; Jong Kyong Kim; Xiaopeng Li; Maria Molina-Molina
Journal:  Curr Pharm Des       Date:  2007       Impact factor: 3.116

View more
  6 in total

Review 1.  Type 2 macrophages and Th2 CD4+ cells in interstitial lung diseases (ILDs): an overview.

Authors:  Neftali Partida-Zavala; Marco Antonio Ponce-Gallegos; Ivette Buendía-Roldán; Ramcés Falfán-Valencia
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

2.  Calpain and spectrin breakdown products as potential biomarkers in tuberculous pleural effusion.

Authors:  Ji Young Hong; So Yeong Park; Youngmi Kim; Chang Youl Lee; Myung Goo Lee
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

3.  A Dataset of 26 Candidate Gene and Pro-Inflammatory Cytokine Variants for Association Studies in Idiopathic Pulmonary Fibrosis: Frequency Distribution in Normal Czech Population.

Authors:  Amit Kishore; Veronika Žižková; Lenka Kocourková; Martin Petřek
Journal:  Front Immunol       Date:  2015-09-22       Impact factor: 7.561

4.  Activation of calpain by renin-angiotensin system in pleural mesothelial cells mediates tuberculous pleural fibrosis.

Authors:  Jie Yang; Fei Xiang; Peng-Cheng Cai; Yu-Zhi Lu; Xiao-Xiao Xu; Fan Yu; Feng-Zhi Li; Peter A Greer; Huan-Zhong Shi; Qiong Zhou; Jian-Bao Xin; Hong Ye; Yunchao Su; Wan-Li Ma
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-06-03       Impact factor: 5.464

5.  Association Study for 26 Candidate Loci in Idiopathic Pulmonary Fibrosis Patients from Four European Populations.

Authors:  Amit Kishore; Veronika Žižková; Lenka Kocourková; Jana Petrkova; Evangelos Bouros; Hilario Nunes; Vladimíra Loštáková; Joachim Müller-Quernheim; Gernot Zissel; Vitezslav Kolek; Demosthenes Bouros; Dominique Valeyre; Martin Petrek
Journal:  Front Immunol       Date:  2016-07-11       Impact factor: 7.561

Review 6.  The Processes and Mechanisms of Cardiac and Pulmonary Fibrosis.

Authors:  Lucy A Murtha; Michael J Schuliga; Nishani S Mabotuwana; Sean A Hardy; David W Waters; Janette K Burgess; Darryl A Knight; Andrew J Boyle
Journal:  Front Physiol       Date:  2017-10-12       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.